Related Experiment Video
Updated: Jul 14, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Bacterial meningitis from Rothia mucilaginosa in patients with malignancy or undergoing hematopoietic stem cell
Alisa B Lee1, Paul Harker-Murray, Patricia Ferrieri
1University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Abstract:
Opportunistic infections contribute to morbidity and mortality of patients undergoing hematopoietic stem cell transplantation and treatment for malignancies. Rothia mucilaginosa, a gram-positive bacterium, is responsible for rare, but often fatal meningitis in severely immunocompromised patients. We describe two cases of meningitis from discrete strains of R. mucilaginosa on our pediatric bone marrow transplant unit, summarize the published cases of R. mucilaginosa meningitis in oncology and stem cell transplant patients, and provide updated recommendations regarding the use of antibiotic therapy in this patient population.
Related Concept Videos
Bacterial Meningitis I: Introduction
Cryptococcal Meningitis
Bacterial Meningitis
Bacterial Meningitis II: Pathophysiology
Viral Meningitis
Rocky Mountain Spotted Fever

